The Global Factor IX Deficiency Treatment Market to grow at a CAGR of 5% during the period 2022-2028. The global factor IX deficiency treatment market is characterized by the presence of a variety of therapeutic products from some top vendors such as Shire, CSL Behring, Novo Nordisk, Biogen and Pfizer. The adoption rate of therapeutics […]
